21 CFR 203.10
§ 203.10 Restrictions on reimportation.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 203.10, § 203.10 Restrictions on reimportation, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/85840
- Permanent ID
ys:prov:85840@1- SHA-256
b6acb35aaf997e5d19ce363b8cecc74257e174e0db281ad38e544933dbe7f9ef
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
No prescription drug or drug composed wholly or partly of insulin that was manufactured in a State and exported from the United States may be reimported by anyone other than its manufacturer, except that FDA may grant permission to a person other than the manufacturer to reimport a prescription drug or insulin-containing drug if it determines that such reimportation is required for emergency medical care.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.